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Objectives: Skin notations are used as a hazard identification tool to flag chemicals associated
with a potential risk related to transdermal penetration. The transparency and rigorousness of
the skin notation assignment process have recently been questioned. We compared different ap-
proaches proposed as criteria for these notations as a starting point for improving and system-
atizing current practice.
Methods: In this study, skin notations, dermal acute lethal dose 50 in mammals (LD50s) and
two dermal risk indices derived from previously published work were compared using the lists
of Swiss maximum allowable concentrations (MACs) and threshold limit values (TLVs) from
the American Conference of Governmental Industrial Hygienists (ACGIH). The indices were
both based on quantitative structure–activity relationship (QSAR) estimation of transdermal
fluxes. One index compared the cumulative dose received through skin given specific exposure sur-
face and duration to that received through lungs following inhalation 8 h at the MAC or TLV. The
other index estimated the blood level increase caused by adding skin exposure to the inhalation
route at kinetic steady state. Dermal-to-other route ratios of LD50 were calculated as secondary
indices of dermal penetrability.
Results: The working data set included 364 substances. Depending on the subdataset, agree-
ment between the Swiss and ACGIH skin notations varied between 82 and 87%. Chemicals with
a skin notation were more likely to have higher dermal risk indices and lower dermal LD50 than
chemicals without a notation (probabilities between 60 and 70%). The risk indices, based on
cumulative dose and kinetic steady state, respectively, appeared proportional up to a constant
independent of chemical-specific properties. They agreed well with dermal LD50s (Spearman
correlation coefficients20.42 to20.43). Dermal-to-other routes LD50 ratios were moderately as-
sociated with QSAR-based transdermal fluxes (Spearman correlation coefficients20.2 to20.3).
Conclusions: The plausible but variable relationship between current skin notations and the
different approaches tested confirm the need to improve current skin notations. QSAR-based risk
indices and dermal toxicity data might be successfully integrated in a systematic alternative to cur-
rent skin notations for detecting chemicals associated with potential dermal risk in the workplace.
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INTRODUCTION
The assessment of occupational health risk has tradi-
tionally focused on inhalation of airborne contami-
nants. Only in the last two decades has the industrial
hygiene community begun to work on the issue of
health risk posed by dermal exposure. This late focus
on the dermal exposure pathway is thought to be due
to the gradual decrease in occupational exposure lim-
its (OELs) since they first appeared, potentially in-
creasing the relative contribution of the dermal
pathway, and to the complexity of assessing dermal
exposure and risk (Fenske, 2000).
Industrial hygiene practitioners therefore still have
a limited set of tools at their disposal to recognize, as-
sess and control the occupational risk related to dermal
penetration. Among them, the skin notation has tra-
ditionally been used to identify substances potentially
associated with such risk. Present in many lists of
OELs proposed by governmental [e.g. the German
maximum allowable concentrations (MACs), (Deutsche
Forschungsgemeinschaft, 2006)] or nongovernmental
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[e.g. the threshold limit values (TLVs), American
Conference of Governmental Industrial Hygienists
(ACGIH) (ACGIH, 2006)] organizations, skin nota-
tions are meant to flag chemicals for which the assess-
ment of inhalation-only exposure might not be
sufficient to adequately evaluate health risk. Their
presence should prompt the expert to perform detailed
dermal exposure and risk assessment or use biological
monitoring to evaluate the total absorbed dose.
The criteria used for assigning a notation generally
include experimental data on dermal absorption in
human or animals, studies reporting toxic effects fol-
lowing skin exposure, in vitro estimates of dermal
penetration, acute dermal toxicity data in animals
and quantitative structure–activity relationship
(QSAR) models, suggesting an elevated skin absorp-
tion potential. While approaches chosen by different
OEL-setting organizations generally include all these
criteria (Nielsen and Grandjean, 2004), consensus on
a specific way to prioritize and interpret them still
seems to be lacking (Sartortelli et al., 2007).
Recently, a comparative study of six lists of OELs
from different countries and organizations showed
important discrepancies in the assignment of skin
notations across these institutions (Nielsen and
Grandjean, 2004). Hence, while all lists contained ap-
proximately the same number of chemicals with a skin
notation (30% of all chemicals), pairwise compari-
sons revealed an average agreement of only 60–70%
between the lists. Scansetti et al. reviewed the docu-
mentation of the 1986 ACGIH TLV list and recorded,
for each chemical with a skin notation, the justifica-
tion for its presence (Scansetti et al., 1988). The most
frequent criterion (40% of all cases) was a dermal le-
thal dose 50 in mammal (LD50),2000 mg kg
1. It is
noteworthy that for 8% of cases, evidence of local ef-
fects to the skin was the cause of the skin notation,
while no rationale was provided for 20% of the cases.
The need for an improvement of the current skin no-
tation system was stressed in a recent international
workshop on this topic (Sartorelli et al., 2007).
Several quantitative criteria for assigning skin no-
tations in a systematic way have been proposed over
the last two decades. Fiserova-Bergerova et al. pro-
posed a simple steady state kinetic model coupled
with QSAR estimates of dermal penetration rates
(Fiserova-Bergerova et al., 1990; Fiserova-Bergerova,
1993). A skin notation would be assigned when skin
exposure caused a significant increase in the blood
level corresponding to inhalation at the OEL. Also
using QSAR for penetration rates, Walker proposed
to calculate a maximal exposure time (for a chosen
exposed surface) corresponding to the dose received
through skin being equivalent to that received through
lungs during a workshift at the OEL (Walker et al.,
1996). A similar approach, comparing the dose re-
ceived through skin after 1-h exposure of the hands
and forearms to the workshift inhalation dose, has
also been evocated (de Cock et al., 1996; Sartorelli
et al., 2007). Kennedy discussed the use of dermal
LD50 in animals as a criterion for skin notations
(Kennedy et al., 1993).
While the advantages and limits of these methods
have been discussed by their respective authors and
others interested in this issue, we found no study at-
tempting to evaluate in a comprehensive manner to
what extent they might agree or not with each other
and with existing lists of skin notations.
Within the framework of the revision of the skin
notation in Switzerland, we applied QSAR-based ap-
proaches to two lists of OELs (the Swiss MACs and
the ACGIH TLVs). One approach is based on Fiserova-
Bergerova et al.’s steady state kinetic model, while
the other is based on the cumulative dose received
through skin, similar to Walker’s proposal. These
two approaches were then compared with current skin
notations in the Swiss and ACGIH OEL lists and
acute dermal toxicity data in animals. The study ulti-
mately aimed at obtaining insight on how to improve
the current use of the concept of skin notation.
METHODS
List of equation terms and their units
 Kp (cm h1): coefficient of permeability
 MW (g mol1): molecular weight
 LogKow: logarithm (base 10) of the octanol-water
partition coefficient
 Jmax (mg cm2 h1): maximal transdermal flux
 Solwater (mg cm3): aqueous solubility
 Valv (m3 h1): alveolar flow rate
 %BL (%): percentage of blood level increase
 OEL (mg m3): occupational exposure limit
 Sexposed (cm2): surface of body exposed
 Sbody (cm2): total body surface (18 000 cm2)
 J* (mg cm2 h1): critical flux
 Cequilibrium (mg cm3): concentration of an aque-
ous solution in equilibrium with an atmospheric
concentration at the OEL
 KHenri (atm m3 mol1): Henri’s law constant
 Vm (l mol1): molar volume at standard tempera-
ture and pressure (STP) (24.4 l mol1).
 V8 h (m3): volume inhaled during an 8-h workshift
 Texposed (h): duration of skin exposure
QSAR model for skin penetration rates
Inherent in the application of the quantitative ap-
proaches mentioned above is the availability of der-
mal penetration rate estimates. Transdermal flux
(J, the amount of chemical penetrating by unit of
time and surface exposed) has been described using
Fick’s law of diffusion for membranes and can be ex-
pressed as the product of a coefficient of permeability
and the concentration of the chemical in the vehicle
(McDougal and Boeniger, 2002). Unfortunately,
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such rates have been measured for only a limited set
of chemicals and, until recently, with lacking stan-
dardization of the experimental settings (Walker
et al., 2003). In order to circumvent the scarcity of ex-
perimental data, QSARs have been established for
skin penetration rates, mainly using the so-called
‘Flynn data set’, a compilation of experimental Kp
values measured in aqueous solution and presented
by Flynn (Flynn, 1990). Several authors have re-
viewed the different QSAR models for skin absorp-
tion (Wilschut et al., 1995; Moss et al., 2002;
Walker et al., 2003; Cronin, 2006; Degim, 2006).
While these models varied in the statistical methods,
data sets, number of predictor variables and penetra-
tion indices modeled, satisfactory results were
obtained by modeling the logarithm of the permeabil-
ity coefficient as a function of molecular weight and
the logarithm of the octanol/water partition coeffi-
cient using multiple linear regression (Potts and
Guy, 1992). Only marginal improvement seems to
have been achieved by adding additional parameters
or using more complex statistical methods compared
to the difficulty of acquiring relevant input informa-
tion. We used the equation estimated by Vecchia
and Bunge, who modeled log(Kp) as a function of
MW and logKow with a refined version of the Flynn
data set (Vecchia and Bunge, 2003). Cronin under-
lined the quality of their effort to improve the original
Flynn data, most notably by adjusting for the fraction
of chemicals in ionized form in experimental data
(Cronin, 2006). Vecchia and Bunge’s QSAR equation
(equation T1 in Table 1 pp. 88–89) is as follows:
Log10ðKpÞ5  2:44þ 0:514  logKow
 0:0050  MW: ð1Þ
Assuming exposure of the skin to a saturated aque-
ous solution of the chemical in question, it is possible
to determine the maximal transdermal flux (in mg
cm2 h1) at steady state:
Jmax5Kp  Solwater: ð2Þ
Where Solwater is the water solubility of the chemical.
Dermal risk indexes
Kinetic approach. This approach is based on the
work by Fiserova-Bergerova et al. (Fiserova-Bergerova
et al., 1990; Fiserova-Bergerova, 1993). The potential
for dermal penetration of a chemical, expressed as
Jmax is compared to a ‘critical flux’ (J*). The critical
flux was defined by the authors as a hypothetical pene-
tration rate through the stratum corneum, which, as-
suming simultaneous skin and inhalation exposure,
causes the biological levels to increase above those
reached during inhalation-only exposure at the OEL
by a prespecified fraction.
Detailed derivation of J* is presented in the appendix
of Fiserova-Bergerova et al. (1990). Briefly, the authors
used different equations for liquids, for which only
a part of the body surface is exposed, and for gases/va-
pors, for which they assumed exposure of the entire
body surface to an aqueous solution in equilibrium
with the atmospheric concentration at the OEL. The
liquid case is directly applicable to solids since we
assume exposure to a saturated aqueous solution.
For the liquid/solid case, the critical flux can be
expressed as:
J5
Valv  %BL  OEL
Sexposed
: ð3Þ
Where Valv is the alveolar flow rate, Sexposed is the skin
surface exposed and %BL is the relative increase in
blood levels at steady state caused by skin exposure.
From equation (3), we define the index RFB as the
ratio of Jmax (equation 2) to J*:
RliqFB5
J max
J
5
J max  Sexposed
Valv  %BL  OEL: ð4Þ
RFB . 1 implies that, assuming toxicokinetic
steady state, exposure to a saturated aqueous solution
of the chemical in question with a simultaneous inha-
lation exposure at the OEL causes an increase of at
least %BL in blood levels compared to an inhala-
tion-only exposure scenario.
For gases and vapors, the authors assumed the
entire surface of skin was exposed to an aqueous
solution of the chemical in equilibrium with an atmo-
spheric concentration at the OEL. Since the equilib-
rium concentration is smaller than the saturated
concentration, the transdermal flux to use in the ki-
netic model is not Jmax (equation 2), but a flux equal
to Kp  Cequilibrium. This correction results in the fol-
lowing expression for the critical flux:
Jgas5
Valv  %BL  OEL
Sbody
 Solwater
Cequilibrium
, ð5Þ
where Cequilibrium can be estimated by:
Cequilibrium5
OEL  Vm
109  KHenri
, ð6Þ
with KHenri the Henri’s law constant for the chemical
and Vm the molar volume at STP.
Equations (5) and (6) can be combined to obtain
RFB for gases.
RgasFB 5
Jmax
J
5
J max  Sbody  Vm
Valv  %BL  Solwater  KHenri  109
:
ð7Þ
Note: while the indices above are based on the ap-
proach published by Fiserova-Bergerova et al., we
did not use their equations for estimating fluxes
which were subsequently shown to overestimate
transdermal passage (Bunge, 1998).
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Cumulative dose approach. The principle of this
approach is to compare the dose received through
skin following a given exposure scenario to that in-
haled during a workshift at the OEL. It differs from
the kinetic approach in that no simultaneous dermal
and pulmonary exposure is assumed. Rather, this
method measures the likelihood that, given a skin ex-
posure scenario, the dose received through skin
might reach the safety threshold dose set for respira-
tory exposure. Variations of this approach have been
described by Walker et al. (1996) and de Cock et al.
(1996) and in the review by McDougall and Boeniger
(McDougal and Boeniger, 2002). We calculated the
ratio of the dermal dose to inhalation dose as follows:
The dose received through inhalation is estimated
assuming 100% pulmonary absorption:
Dinh5OEL  V8 h, ð8Þ
with V8 h the volume inhaled during an 8-h shift.
The cutaneous dose is expressed as:
Dcut5 J  Sexposed  Texposed, ð9Þ
with Texposed exposure duration. Sexposed and J are the
exposed surface and transdermal flux, both different
for liquids/solids and gases/vapors:
Dliqcut5 J max  Sexposed  Texposed, ð10Þ
Dgascut 5 J max 

Cequilibrium
Solwater

 Sbody  8 h:
ð11Þ
This yields the following expressions for the ratios
cutaneous/inhalation:
Rliqcut=inh5
Dliqcut
Dinh
5
J max  Sexposed  Texposed
OEL  V8 h ,
ð12Þ
Rgascut=inh5
Dgascut
Dinh
5
J max  Sbody  Vm  8 h
Solwater  V8 h  109  KHenri
:
ð13Þ
Rcut/inh . 1 implies that exposure during 8 h to
a saturated aqueous solution of the chemical in ques-
tion causes absorption of a dose at least equivalent to
that which would have been received after inhalation
exposure at the OEL during 8 h.
Choice of exposure scenarios. Both the kinetic and
cumulative dose approaches require selection of an
exposed skin surface for exposure to liquids and sol-
ids, the latter also having exposure duration as an in-
put. We selected arbitrarily an exposed surface of
both hands (surface 840 cm2) and an exposure dura-
tion of 8 h. Fiserova-Bergerova et al. selected an
exposed surface of 2% of total body surface,
corresponding to the palms of both hands (Fiserova-
Bergerova et al., 1990). In Walker’s approach
(Walker, 1996), one hand is considered, while both
hands and forearms during 1 h is the scenario men-
tioned in de Cock et al. (1996).
Database construction
The starting database for this study was the list of
OELs enforced in Switzerland by the Swiss Accident
Insurance Fund (SUVA), which contains names,
CAS numbers and regulatory OELs of 700 chemi-
cals. Information from the 2006 ACGIH TLVs and
BEIs CDROM were then added. Physicochemical
characteristics were retrieved using the PHYSPROP
database (Syracuse Research Corporation, North
Syracuse, NY, USA), which contains experimental,
extrapolated, and estimated property values for over
40 000 chemicals.
Acute toxicity data was obtained through purchase
of the Registry of Toxic Effects of Chemical Substan-
ces (RTECS), a compendium of data extracted from
the open scientific literature which contains acute
toxicity values for .130 000 chemicals. Due to the
scarcity of acute toxicity data, we included in our
study LD50s for all mammals. For each chemical,
the lowest of all available LD50 values was selected
for each exposure route. LD50 data other than dermal
were retrieved in order to calculate ratios of dermal
to other routes ratios, used as proxies for the ability
of a chemical to penetrate the skin. For each sub-
stance and for a specific comparison route (e.g. der-
mal to oral), the ratios were derived as follows: all
available data were restricted to values available for
both routes for at least one species. Then for each
species, the lowest LD50 value was selected for each
route and a ratio dermal/comparison route was calcu-
lated. The final ratio for the chemical in question was
taken as the geometric average of the minimum and
maximum ratios obtained with the different species.
The dermal LD50 data were also used to create
a categorical variable simulating the ‘risk phrases’
used in the European Community to characterize
risks associated with chemicals (see Annex III of
European Union Directive 67/548/EEC, consolidated
in Directive 2001/59/EC). Three such phrases refer
specifically to health risks posed by penetration
through skin: R21 Harmful in contact with skin,
R24 Toxic in contact with skin and R27 Very toxic
in contact with skin. These phrases are assigned to
a chemical depending on the value of the dermal
LD50 in rats or rabbits with the following limits:
R21 400 , LD50 , 2000 mg kg
1, R24 50 ,
LD50 , 400 mg kg
1 and R27 LD50 , 50 mg kg
1.
RESULTS
Description of the databases
Abstracting the SUVA list of OELs yielded an ini-
tial database of 668 substances with a unique CAS
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number. This database was refined by eliminating
substances for which the skin penetration models
are not relevant, i.e. dusts, fibers, metals and metallic
oxides, and substances classified as corrosive accord-
ing to the EC classification (risk phrases R34 and
R35). Further elimination of chemicals with missing
input parameters, without a numerical 8-h OEL in the
SUVA list or having values of molecular weight or
logKow outside of the modeling space recommended
by Vecchia and Bunge (MW between 18 and 500 g
mol1 and logKow between –1.3 and 4.27) (Vecchia
and Bunge, 2003) yielded a data set of 364 substan-
ces (data set BD1). The 509 dermal LD50s retrieved
in our study spanned the years 1915–2005, with
1974 as the median year.
Gases/vapors versus liquids/solids. As mentioned
by McDougall and Boeniger (2002), penetration
through skin of gases and vapors can in most cases
be considered as minor compared to the inhalation
route. This is reflected in the equations above by the
fact that the transdermal flux is not calculated with
the saturation concentration of a chemical, but with
a concentration in equilibrium with the atmospheric
contamination, resulting in most cases in a much small-
er flux. Figure 1, which shows a boxplot of the Rcut/inh
index calculated with the SUVA OELs applied to the
data set BD1 stratified by physical state at STP, clearly
illustrates the bimodality of the distribution of the in-
dex values. To avoid potential confounding by the
physical state, we therefore excluded gases and vapors
from subsequent analyses. This yielded a data set BD2
of 320 chemicals. Table 1 presents descriptive statistics
for the parameters of interest in this study in BD2.
OELs based on sensory irritation. A limitation as-
sociated with using inhalation OELs to estimate an
internal threshold dose is that the toxic end point
used to derive the OEL may not be relevant to sys-
temic effects following absorption through skin
(Fiserova-Bergerova et al., 1990; Bos et al., 1998;
Nielsen and Grandjean, 2004). In particular, a number
of OELs are based on irritation of the respiratory
tract or eyes. Since the basis of an OEL is supposed
to be the effect occurring at the lowest dose, calculat-
ing a risk index based on irritation will cause an over-
estimation of risk, the extent of which is unknown.
For the ACGIH list, the OELs were distributed as fol-
lows: 66 based on irritation and 191 based on other
effects. We obtained the data set BD.ACGIH by
eliminating irritation-based OELs. The Swiss book-
let does not indicate the critical effect of OELs and
there is no publicly available documentation of these
OELs. The Swiss OELs being very close to the
German MAC values (Prof. Michel Guillemin, Swiss
OEL committee), we imputed the rationale for the
Swiss OELs using the German values. The OELs
were distributed as follows: 57 based on irritation,
199 based on other effects and 64 unknown ration-
ales. Keeping only OELs based on other effects
yielded the data set BD.SUVA.
Theoretical correspondence between RFB and
Rcut/inh
Equations (4), (7), (12) and (13) can be combined
to obtain analytical formulas for the ratio Rcut/inh/
RFB:
Rcut=inh
RFB
ðliquid=solidÞ5Valv  %BL  Texposed
V8 h
,
ð14Þ
Rcut=inh
RFB
ðgas=vaporÞ5Valv  %BL  8 h
V8 h
:
The two approaches can therefore be taken as
equivalent save for a proportionality factor that does
not depend on the chemical studied. With Texposed 5
8 h, V8 h 5 10 m
3 (Paustenbach, 2003) and Valv 5
0.9 m3 h1 (Fiserova-Bergerova et al., 1990) and
%BL 5 30% (as in the paper by Fiserova et al.),
the ratio is 0.22. In this case, the kinetic approach
is more conservative than the cumulative dose ap-
proach. Considering this analytical correspondence,
we limited the subsequent analyses to the Rcut/inh index.
Relationship between SUVA and ACGIH lists
Using the initial SUVA list restricted to substances
present in the 2006 TLV booklet (n5 501), Skin no-
tations in both lists agreed for 87% of chemicals,
with 45 substances with a SUVA skin notation but
without an ACGIH skin notation and 21 substances
without a SUVA notation but with an ACGIH nota-
tion. Restricting the comparison to the smallest data
set in our analysis (BD.ACGIH, n 5 191) yielded
82% of agreement, with 26 SUVA/non-ACGIH and
9 non-ACGIH/SUVA situations.
Relationship between Rcut/inh and current skin
notations
Figure 2 shows variations of the Rcut/inh index for
chemicals with and without a SUVA skin notation
Fig. 1. Variation of the dermal to inhalation ratio (Rcut/inh) as
a function of the physical state of chemicals.
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(data set BD.SUVA). The results were similar for the
ACGIH notation (data set BD.ACGIH), with a me-
dian Rcut/inh of 3.6 for chemicals with a skin notation
and 0.2 for those without. The discriminating power
of Rcut/inh can be expressed as the fact that a chemical
randomly chosen within the ‘skin notation’ group of
the SUVA list had a probability of 61% of having
Rcut/inh higher than a chemical without a skin nota-
tion (72% for the ACGIH list). Looking at variations
of the two determinant parameters of Rcut/inh, Jmax
and the OEL values, their median for chemicals with
and without a notation were 0.033 versus 0.025 mg
cm-2 h-1 and 3.2 versus 12.5 mg m3, respectively,
for the Swiss list. The values were 0.026 versus
0.023 mg cm-2 h-1 and 4.6 versus 35.2 mg m3 for
the ACGIH list.
Relationship between acute dermal toxicity data
and current skin notations
Figure 3 shows variations of the dermal LD50 in
mammals with and without a SUVA skin notation.
Since the OELs and their critical effect were not rel-
evant in this comparison, we used the data set BD2
restricted to chemicals for which a LD50 was avail-
able (n 5 149) in this analysis. Among the 57 chem-
icals without a skin notation, 19 and 5 were in the
categories 400 , LD50 , 2000 and 50 , LD50 ,
400 mg kg1, respectively; two substances (Fensul-
fothion CAS 115-90-2, Disulfoton CAS 298-04-4)
had a dermal LD50 , 50 mg kg
1. Comparing the
dermal LD50 with the ACGIH classification yielded
a similar pattern. There were 136 LD50 available,
and the median values were 400 and 3228 mg kg1
for chemicals with and without a skin notation, re-
spectively. Among the 63 chemicals without a skin
notation, 30 and 4 were in the categories 400 ,
LD50 , 2000 and 50 , LD50 , 400 mg kg
1, re-
spectively. Of the 30 substances with 400 , LD50 ,
2000, 23 had a LD50 .1000 mg kg
1, a criterion
mentioned in the 2006 TLV booklet. A substance
without a skin notation in the SUVA list had a 64%
chance of having a higher LD50 than a substance with
a notation (72% for the ACGIH list).
Relationship between Rcut/inh and acute dermal
toxicity data
Figure 4 shows the variations of Rcut/inh calculated
with the SUVA OELs (BD.SUVA) as a function of
acute dermal toxicity categories. The Spearman
Table 1. Descriptive statistics for parameters in the working database
Variable Minimum First quartile Median Third quartile Maximum n
MWa (g mol1) 27 99 129 199 461 320
Pvapb (mmHg) 1.3  1013 0.0013 1.29 21.07 760 320
Solc (mg l1) 0.2 222 4820 60 500 1 000 000 320
LogKow
d 1.28 0.58 1.60 2.70 4.21 320
SUVA-OELe (mg m3) 0.001 0.5 10 100 4 200 320
ACGIH-OELf (mg m3) 0.0047 1.27 10.15 203 7 664 257
Kpg (cm h1) 4.6  105 0.0018 0.0044 0.0106 0.1360 320
Jmaxh (mg cm2 h1) 3.5  107 0.0026 0.0275 0.1340 3.71 320
Rcut/inh SUVA
i 7.8  105 0.13 1.22 17.80 1.74  105 320
Rcut/inh ACGIH
j 1.3  104 0.08 0.77 9.73 2.19  104 257
LD50
k (mg kg1) 0.75 300 1580 5070 3.44  104 149
aMolecular weight.
bVapor pressure.
cWater solubility.
dLogarithm (base 10) of the octanol/water partition coefficient.
e8 h occupational exposure limit in the SUVA list.
f8 h occupational exposure limit in the ACGIH list.
gModeled skin permeability coefficient.
hModeled transdermal maximal flux.
iRcut/inh calculated with the SUVA OEL.
jRcut/inh calculated with the ACGIH OEL.
kLethal dose 50 in mammals.
Fig. 2. Variations of the dermal to inhalation ratio (Rcut/inh) as
a function of presence or absence of a Swiss skin notation.
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correlation coefficient between Rcut/inh and the LD50
values was 0.42 (P 5 0, n 5 90). Again, a similar
pattern was observed with the ACGIH values (data
set BD.ACGIH), with the following median Rcut/inh
values: 39 for LD50 , 50 mg kg
1, 10 for 50 ,
LD50 , 400 mg kg
1, 4 for 400 , LD50 , 2000
mg kg1 and 1 for LD50. 2000 mg kg
1. The Spear-
man correlation coefficient between Rcut/inh and the
LD50 values was 0.43 (P 5 0, n 5 102). Looking
at Jmax and the OEL values for the Swiss list, the
correlation coefficients with the LD50 were 0.03
(P 5 0.73) and 0.6 (P 5 0), respectively. These val-
ues were 0.20 (P 5 0.05) and 0.74 (P 5 0) for the
ACGIH list.
Relationship between transdermal penetration
parameters and ratios of LD50
Table 2 shows the Spearman correlation coeffi-
cients between the different parameters used to esti-
mate skin penetration (Jmax, Kp and Solwater) and the
ratios of dermal to other route LD50 estimated from
RTECS. The results are presented for the whole
PHYSPROP data for which Jmax and Kp could be
estimated within the modeling space defined by
Vecchia and Bunger (2003) and for the main working
data set (BD2).
DISCUSSION
Few tools are available to industrial hygienists to
assess the systemic toxic risk posed by skin exposure
to chemical at the workplace. Quite recently, concep-
tual models for skin exposure have been presented
that mark the emergence of this particular field
(Schneider et al., 1999). RISKOFDERM (Oppl
et al., 2003), aimed at ‘educated nonexperts’, pro-
vides a risk banding approach similar to the COSHH
Fig. 3. Variations of the dermal LD50 in mammals as
a function of presence or absence of a Swiss skin notation.
Fig. 4. Variations of the dermal to inhalation ratio (Rcut/inh) as
a function of acute dermal toxicity categories.
Table 2. Spearman correlation coefficients between dermal penetration parameters and ratios of dermal LD50 to LD50
from other exposure routes
Route n Jmaxa Kpb Solwater
c
Full databased
Oral 451 0.16 (,0.01)e 0.15 (,0.01) 0.07 (0.14)
Intraperitoneal 180 0.08 (0.27) 0.03 (0.66) 0.04 (0.56)
Intravenous 79 0.23 (0.04) 0.017 (0.88) 0.23 (0.04)
Working databasef
Oral 93 0.34 (,0.01) 0.02 (0.83) 0.28 (,0.01)
Intraperitoneal 51 0.18 (0.21) 0.01 (0.96) 0.14 (0.31)
Intravenous 31 0.33 (0.07) 0.09 (0.62) 0.21 (0.25)
aMaximal transdermal flux.
bSkin permeability constant.
cWater solubility.
dAll chemicals in PHYSPROP for which Jmax could be estimated within the modeling space defined by
Vechia and Bunge (2003).
eP value associated with the correlation coefficient estimate.
fData set BD2.
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toolbox (Jones and Nicas, 2006). The risk analysis is
based on the European risk phrases and assumes
100% skin absorption in most cases. The DREAM
model based on the work of Schneider et al. provides
an interesting semiquantitative approach to dermal
exposure assessment, but does not consider risk
(Van-Wendel-De-Joode et al., 2003). The skin nota-
tions therefore still appear as the main tool providing
the industrial hygienist with a signal that they should
consider the skin pathway in their assessment. It is
therefore important that efforts be made to improve
their rationale and justification.
Current skin notations
The two OEL lists examined in our study, the
Swiss MAC values and the ACGIH TLVs, proved
to be somewhat closer to each other than what could
have been expected considering the results from
Nielsen and Grandjean (2004). The higher agreement
in our study comes from the fact that we looked at
chemicals common to both classifications, whereas
Nielsen et al. counted chemicals with a skin notation
regardless if they were present in other lists. Despite
these more favorable figures, hygienists looking for
information will still get a contradictory message in
close to 20% of cases.
Comparing the QSAR-based risk index for chem-
icals with and without a skin notation yielded a plau-
sible but variable relationship, chemicals with a skin
notation having generally a higher dermal risk ac-
cording to Rcut/inh. The association appeared to be
due to differences in OELs between chemicals with
and without notations rather than differences in esti-
mated transdermal flux.
A similar trend was observed with acute toxicity
data, i.e. generally lower LD50 for chemicals with
a skin notation. In this case, the contrast between
chemicals with and without a skin notation was high-
er for the ACGIH list. This is probably explained by
the explicit mention of a dermal LD50 criterion in the
TLV booklet (1000 mg kg1). Kennedy et al., before
any numerical criterion was mentioned in the TLV
booklet, observed that the relationship between the
presence of a skin notation and dermal LD50 values
was unclear and recommended a criterion of
1000 mg kg1. Fifteen years after this criterion was
implemented (1991–1992), the relationship is
clearer, but 11 substances without a skin notation still
have LD50 values ,1000 mg kg
1, of which four
are ,400 mg kg1.
Comparison of the cumulative dose and
kinetic approaches
The two QSAR-based approaches described in our
study, although based on different assumptions,
proved to be proportional, the proportionality being
chemical independent. In fact, using a skin exposure
duration equivalent to the inhalation exposure dura-
tion, and simplifying the alveolar flow rate as equal
to the respiratory flow rate, the ratio between the two
indices reduces to %BL. A doubling of the blood levels
(%BL5 100%) corresponds to equivalence of the two
approaches. This is explained by the fact that at steady
state, the blood levels estimated using the simple
kinetic model described by Fiserova-Bergerova et al.
are proportional to the exposure dose rate. Hence,
the two approaches differ only in that one compares
dose rates while the other compares doses. They be-
come numerically equivalent when inhalation and der-
mal exposure durations are equal.
Comparison of the QSAR-based approaches and
acute dermal toxicity
We observed a moderate-to-good agreement be-
tween the QSAR-based indices and the available
acute dermal toxicity (Spearman correlation
0.45). This agreement appeared due mainly to the
strong inverse correlation between the LD50s and
the OELs and somewhat puts into question the rele-
vance of our transdermal flux estimates. However,
the possibility to calculate dermal to other route ra-
tios of LD50 for a number of chemicals in our study
offered a means of validating ‘externally’ these pen-
etration rates. The observed correlation coefficients
showed a weak-to-moderate but statistically signifi-
cant inverse relationship with Jmax and the water
solubility, while the relationship with Kp was less
clear (see Table 2). Given the variability linked with
the derivation of the LD50 ratios (e.g. animals may
have been exposed to the neat chemical), our results
suggest that the estimated penetration rates actually
influence the relation between dermal and other route
acute toxicity and are relevant to the risk assessment.
Finally, the fact that the relationship with dermal to
other route ratios seems stronger for the maximal flux
and the water solubility than with the permeation
constant is noteworthy. Indeed, Jmax is estimated by
the product ofKp and Solwater, and Solwater is available
for many compounds in a reliable manner. Then, it
could be inferred that although Kp values are associ-
ated with much uncertainty because of QSARs based
on a limited data set, this uncertainty is not critical in
estimating the risk associated with dermal exposure.
Mechanistically, the possible predominance of the
solubility versus Kp in determining the flux has been
mentioned (Boeniger, 2003). Our results are, how-
ever, too limited to draw any firm conclusion on this
issue and making the same comparison using avail-
able experimental data would be informative.
Exposure scenarios
Since our study was comparative, our particular
choice of exposure scenario had no impact on the
conclusions drawn. In assessing risk, however, abso-
lute values of the indices will be needed and scenar-
ios will have to be selected, each single one being
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probably not universally realistic (de Cock et al.,
1996). Developing further the proposition of
Walker’s maximal skin exposure time (Walker
et al., 1996), an index based on the product of expo-
sure duration and surface (e.g. a maximum time 
surface, in h cm2 corresponding to a dermal dose
equal to the inhalation dose) might allow a wider
space of scenarios to be included in the assessment.
Such an approach is currently being developed at
the Institute for Work and Health.
Limitations of each single method: a case for an
integrated approach
The limits associated with each approach used in
this study have generally been discussed by their au-
thors or in reviews (see for example, McDougall and
Boeniger, 2002). They can be separated in two cate-
gories: limitations due to assumptions and simplifica-
tion of the real skin exposure and absorption process
(e.g. exposure to a saturated aqueous solution and in-
finite dose/steady state scenarios or use of acute ani-
mal toxicity data as opposed to chronic human data)
and limitations due to circumstances in which data
are not available or not relevant for their implemen-
tation (e.g. an elevated LD50 is not useful because it
indicates low acute toxicity but says nothing about
potential chronic effects at low doses or the OEL is
based on irritation). The first category involves in
particular the uncertainty of current QSARs for der-
mal penetration, which according to some authors
should be only used for hazard identification (Van-
de-Sandt et al., 2007). In our view, such limitations
are not much different than those existing in many
risk assessment approaches and gradual improve-
ment of experimental data and sensitivity analysis
methods can help reduce their impact. Examples of
advances in the field include the elaboration of a da-
tabase of standardized in vivo and in vitro experimen-
tal permeation data within the EDETOX project and
attempts to estimate finite dose permeation from in-
finite dose experiments (Kruse et al., 2007;). The sec-
ond category of limitations can be circumvented, at
least partially, by using an integrated approach.
Hence, while elevated acute LD50 are not informa-
tive, a low value certainly provides insight into po-
tential dermal effects in human. On the other hand,
a QSAR-based index using an OEL based on sensory
irritation, although overestimating risk, will be useful
if resulting in a low-risk prediction.
CONCLUSION
The approaches presented here cover only some
aspects of the ‘ideal’ skin notation process, which
is, for example, more thoroughly addressed in the po-
sition paper by Sartorelli et al. (2007). Thus, issues
such as those of mixtures and penetration enhancers
are not included. In particular, experimental penetra-
tion data and human dermal toxicity data are avail-
able for a number of chemicals and represent
stronger evidence than the modeling approaches pre-
sented here. The purpose of our study was not to pro-
pose a new ‘skin notation method’, but to compare
quantitative approaches that can be implemented
for many chemicals. In this regard, we think these ap-
proaches can be successfully included as part of
a global algorithm making use of all information
available in a systematic and predefined way.
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